WebJul 2, 2024 · Sherlock Biosciences and binx health have announced the companies have entered into a strategic partnership to develop the world’s first rapid, point-of-care diagnostic test for COVID-19 leveraging CRISPR technology. The organizations will combine the binx io diagnostic platform with SHERLOCK™ CRISPR technology to create a test that is robust … WebSherlock Biosciences aims to disrupt diagnostics by providing accurate, actionable information wherever and whenever it is needed. Powered by CRISPR and synthetic …
Sherlock Biosciences - Overview, News & Competitors
WebMar 9, 2024 · Sherlock Biosciences has raised $80m in a Series B financing led by Novalis LifeSciences to develop new at-home diagnostic tests.. The financing round included … WebSherlock Biosciences announced today that it appointed Maurice Exner as its first chief scientific officer.. Watertown, Massachusetts-based Sherlock said Exner will serve as a member of its executive leadership team. His responsibilities include driving the company’s scientific research strategy. rustbond primer
Sense Announces Agreement to be Acquired by Sherlock …
WebJul 1, 2024 · The assay uses one of Sherlock Bio's foundational platforms — the SHERLOCK platform, which was first developed by Feng Zhang's team at the Broad Institute in April 2024. SHERLOCK combines various CRISPR-Cas enzymes such as Cas13, Cas12a, and Csm6 to allow for the simultaneous detection of multiple nucleic acids. WebFeb 1, 2024 · Sherlock Biosciences has bought global molecular diagnostics company Sense Biodetection based out of Cambridge, U.K., to help it reach its goal of making … WebApr 13, 2024 · Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced that veteran research and development executive Maurice Exner has been appointed as the company’s first Chief Scientific Officer. In his new role, Exner will serve as a member of the company’s … rustbond fc